The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with ...

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

Please provide your email address to receive an email when new articles are posted on . Earlier initiation of donanemab reduced the risk of disease progression on the Clinical Dementia Rating-Global ...

Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about ...

However, lecanemab doesn’t stop the relentless march of Alzheimer’s disease, it just slows it down. The medication, sold under the brand name Leqembi, also comes with a hefty price tag and a risk of ...

ADAS-Cog13 difference −12.78 (P < 0.0001) with oral blarcamesine treatment compared to ADNI control group at Week 144 77.4 ...

Reduced kidney function from chronic kidney disease may undermine the accuracy of blood-based biomarkers used to predict AD outcomes.

Please provide your email address to receive an email when new articles are posted on . Active intervention correlated to better cerebral blood flow in areas of memory, executive function and language ...

CHARLESTON — The Alzheimer’s Association has launched a new, free app to help those in the early stages of the disease and their loved ones navigate a dementia diagnosis. According to a release ...

A new research paper documents the outcomes of five volunteers who continued to receive 40Hz light and sound stimulation for ...